PPL Regulates AKT Phosphorylation and Affects Ovarian Cancer Progression

Lijing Liu,Lin Ding,Lanli Zhang,Hongtao Zhang,Yu Zhang,Dan Liu

DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.20233712.665

2023-01-01

Journal of biological regulators and homeostatic agents

Abstract:Background: Ovarian cancer (OC) is a highly malignant disease, and due to its high recurrence rate, high chemotherapy resistance, and lack of effective early diagnostic methods, effective targets for early screening, treatment, and prognosis prediction are necessary for research in this field. This study aimed to investigate the mechanism of periplakin (PPL) in malignant development of ovarian cancer and provide references for the treatment of ovarian cancer.Methods: We performed a The Cancer Genome Atlas (TCGA) analysis of RNA seq data from clinical tumor sample, and ana-lyzed PPL expression levels in tumors and adjacent tissues in Clinical Proteomic Tumor Analysis Consortium (CPTAC) data. We obtained information related to PPL and patient prognosis in clinical tumor samples of ovarian cancer from the TCGA database, including the expression level of PPL in various epithelial cell cancers and the correlation between PPL expression and patient survival. Then, we analyzed the relationship between PPL expression and ovarian cancer development. Also, we collected clinical tumor samples and used the enzyme-linked immunosorbent assay (ELISA) to detect the difference in PPL expression between tumor tissue and adjacent tissues. We constructed a stable knockdown SKOV3 ovarian cancer cell line with PPL. The western blot (WB) technique was used to detect the expression level of PPL and the protein kinase A (AKT) in the experimental group and control group after downregulation. 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay was utilized to detect the changes in the growth and proliferation of SKOV3 ovarian cancer cell lines in the control (shctrl) and experimental (shPPL#1, shPPL#2, and PPL Flag) groups after knocking down PPL. The control (BALB/c shctrl) and the experimental (BALB/c shPPL#1 and BALB/c shPPL#2) groups were used to detect the effect of knocking down PPL on the growth of ovarian cancer cells in situ transplanted into mouse models.Results: Among various human tumors, the majority of people suffer from ovarian cancer. We found that the relative expression level of PPL gene in ovarian cancer is high. Analysis of CPTAC data showed an increase in PPL expression levels in ovarian cancer tissues compared to normal tissues. Knocking down PPL significantly affects the growth of ovarian cancer cells and inhibits the proliferation and migration of ovarian cancer cells. PPL knockdown significantly alters the phosphorylation level of AKT in the SKOV3 ovarian cancer cell line. The results of orthotopic transplantation were similar to those in cell lines. The tumor weight and volume in the experimental group were smaller than those in the control group. Knocking down PPL could reduce the p-AKT activity of transplanted mice.Conclusions: PPL plays a crucial role in the proliferation and migration of ovarian cancer tumors. It regulates the phosphorylation of AKT and affects the proliferation and migration of ovarian cancer cells. Targeting PPL may serve as a new therapeutic target in ovarian cancer patients.